Dose-dependent biotransformation of arsenite in rats--not S-adenosylmethionine depletion impairs arsenic methylation at high dose.
Arsenite (AsIII) is eliminated via excretion and methylation. Monomethylarsonous acid (MMAsIII) is a super toxic metabolite of AsIII, while dimethylarsinic acid produced in the next metabolic step is relatively atoxic. Since the role of methylation in the acute toxicity and elimination of AsIII in vivo is unclear, we have examined the excretion and tissue retention of AsIII and its metabolites in rats exposed to increasing AsIII doses. Rats were injected i.v. with 20, 50 and 125 micromol/kg AsIII and arsenic metabolites in bile, urine and tissues were analysed. The excretion of AsIII increased almost proportionately to the dose, while its concentration in tissues rose more than proportionately. In contrast, the excretion and tissue concentrations of methylated metabolites increased less than the dosage, or they even decreased after injection of the largest dose of AsIII. To elucidate the mechanism of the dose-dependent decrease of methylation, we quantified S-adenosylmethionine (SAME), glutathione (GSH), and adenine nucleotides in the liver of AsIII-injected rats. AsIII decreased the hepatic concentrations of GSH and adenosine 5'-triphosphate (ATP) and the energy charge in a dose-dependent manner, but increased the level of SAME. Thus, impaired methylation after AsIII overdose is not due to SAME shortage, but probably to methyltransferase inhibition. It appears that exhausted elimination capacity of AsIII, rather than MMAsIII produced from AsIII, contributes significantly to the acute toxicity of AsIII. After GSH depletion the retained AsIII can increasingly inhibit SH-enzymes, thus causing ATP depletion and energetic disorder.
Csanaky
Iván
I
Department of Pharmacology and Pharmacotherapy, University of Pécs, Medical School, Szigeti út 12, H-7643 Pecs, Hungary.
Németi
Balázs
B
Gregus
Zoltán
Z
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D018053:Arsenites / Q000097:blood / Q000493:pharmacokinetics* / Q000652:urine; D001646:Bile / Q000737:chemistry; D001711:Biotransformation; D002101:Cacodylic Acid / Q000097:blood / Q000378:metabolism / Q000652:urine; D004305:Dose-Response Relationship, Drug; D005978:Glutathione / Q000378:metabolism; D007668:Kidney / Q000737:chemistry; D008099:Liver / Q000737:chemistry / Q000378:metabolism*; D008297:Male; D008745:Methylation; D009206:Myocardium / Q000737:chemistry; D009942:Organometallic Compounds / Q000097:blood / Q000378:metabolism / Q000652:urine; D051381:Rats; D017208:Rats, Wistar; D012435:S-Adenosylhomocysteine / Q000378:metabolism; D012436:S-Adenosylmethionine / Q000172:deficiency / Q000378:metabolism*
D018053:Arsenites; D009942:Organometallic Compounds; C406082:monomethylarsonous acid; D012436:S-Adenosylmethionine; D000255:Adenosine Triphosphate; D012435:S-Adenosylhomocysteine; D002101:Cacodylic Acid; D005978:Glutathione; C015001:arsenite